Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Notes Payables (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Notes Payables for 3 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Notes Payables fell 83.95% year-over-year to $1.6 million, compared with a TTM value of $1.6 million through Sep 2025, down 83.95%, and an annual FY2024 reading of $26255.0, down 99.22% over the prior year.
  • Notes Payables was $1.6 million for Q3 2025 at SBC Medical Group Holdings, down from $3.3 million in the prior quarter.
  • Across five years, Notes Payables topped out at $10.2 million in Q3 2024 and bottomed at $26255.0 in Q4 2024.
  • Average Notes Payables over 3 years is $3.2 million, with a median of $2.7 million recorded in 2024.
  • The sharpest move saw Notes Payables crashed 99.22% in 2024, then rose 21.19% in 2025.
  • Year by year, Notes Payables stood at $3.4 million in 2023, then plummeted by 99.22% to $26255.0 in 2024, then soared by 6136.41% to $1.6 million in 2025.
  • Business Quant data shows Notes Payables for SBC at $1.6 million in Q3 2025, $3.3 million in Q2 2025, and $1.4 million in Q1 2025.